First tricyclic oximino derivatives as 5-HT3 ligands.

The design and synthesis of a new type of 5-HT3 ligand with subnanomolar affinity are described. The O-dialkylaminoethyloximinothienopyrrolizine structure was deduced from molecular modeling studies by replacement of an amidine moiety by an oximino one.

[1]  P Delagrange,et al.  Novel selective and partial agonists of 5-HT3 receptors. Part 1. Synthesis and biological evaluation of piperazinopyrrolothienopyrazines. , 1996, Journal of medicinal chemistry.

[2]  Ronan Bureau,et al.  Conformational Analysis and 3D QSAR Study on Novel Partial Agonists of 5‐HT3 Receptors , 1996 .

[3]  M. Rapport,et al.  Serum vasoconstrictor, serotonin; isolation and characterization. , 1948, The Journal of biological chemistry.

[4]  Andrew Smellie,et al.  Poling: Promoting conformational variation , 1995, J. Comput. Chem..

[5]  P Delagrange,et al.  Novel and selective partial agonists of 5-HT3 receptors. 2. Synthesis and biological evaluation of piperazinopyridopyrrolopyrazines, piperazinopyrroloquinoxalines, and piperazinopyridopyrroloquinoxalines. , 1997, Journal of medicinal chemistry.

[6]  D. Hoyer,et al.  Identification of serotonin 5-HT3 recognition sites by radioligand binding in NG108-15 neuroblastoma-glioma cells. , 1987, European journal of pharmacology.

[7]  Gavin Kilpatrick,et al.  5‐HT3 receptors , 1990, Annals of the New York Academy of Sciences.

[8]  M. Hamon,et al.  Novel and highly potent 5-HT3 receptor agonists based on a pyrroloquinoxaline structure. , 1997, Journal of medicinal chemistry.

[9]  S. Rault,et al.  A convenient synthesis of new aminopyrroloindoles via an imminium salt , 1985 .

[10]  T. Langer,et al.  Novel potent and selective central 5-HT3 receptor ligands provided with different intrinsic efficacy. 1. Mapping the central 5-HT3 receptor binding site by arylpiperazine derivatives. , 1998, Journal of medicinal chemistry.

[11]  Gavin Kilpatrick,et al.  The pharmacological characterization of 5‐HT3 receptors in three isolated preparations derived from guinea‐pig tissues , 1990, British journal of pharmacology.

[12]  E. Novellino,et al.  Pyrroloquinoxaline derivatives as high-affinity and selective 5-HT(3) receptor agonists: synthesis, further structure-activity relationships, and biological studies. , 1999, Journal of medicinal chemistry.

[13]  Trevor Sharp,et al.  A review of central 5-HT receptors and their function , 1999, Neuropharmacology.

[14]  M. Hamon,et al.  Novel potent and selective central 5-HT3 receptor ligands provided with different intrinsic efficacy. 2. Molecular basis of the intrinsic efficacy of arylpiperazine derivatives at the central 5-HT3 receptors. , 1999, Journal of medicinal chemistry.